共 411 条
[1]
Albain KS(2010)Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Lancet Oncol 11 55-65
[2]
Barlow WE(2015)Prospective validation of a 21-gene expression assay in breast cancer N Engl J Med 373 2005-2014
[3]
Shak S(2010)Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population Cancer 116 3112-3118
[4]
Hortobagyi GN(2004)A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817-2826
[5]
Livingston RB(2006)Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 3726-3734
[6]
Yeh IT(2008)Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features J Clin Oncol 26 4063-4071
[7]
Ravdin P(2016)Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology Clinical practice guideline J Clin Oncol 34 1134-1150
[8]
Bugarini R(2021)21-Gene assay to inform chemotherapy benefit in node-positive breast cancer N Engl J Med 385 2336-2347
[9]
Baehner FL(2017)Breast cancer—major changes in the American Joint Committee on Cancer eighth edition cancer staging manual CA Cancer J Clin 67 290-303
[10]
Davidson NE(1999)Clinical and histological predictors of contralateral breast cancer Eur J Surg Oncol 25 584-589